Results per Page:
Mining single cell transcriptomes for antibody gold
From the Goo Lab, Vaccine and Infectious Disease Division
Escaping flavivirus-neutralizing antibodies
From the Goo lab, Vaccine and Infectious Disease Division, and the Bloom lab, Basic Science Division
Early research may show new way to block dengue and Zika virus
Scientists find different flavor of broadly neutralizing antibody that could lead to new vaccines for growing threat
Screening with bioinformatics for new dengue cross-serotype antibodies
From the Vaccine and Infectious Disease Division and the Chan Zuckerberg Biohub.
Science on the horizon
Fred Hutch experts make predictions for science trends, advances in 2020
Dengue virus evolution drives multiple disease outcomes
From the Bedford lab, Vaccine and Infectious Disease Division
First licensed dengue vaccine withstands rainy season
From the Vaccine and Infectious Disease Division
Closer is better
From the Gilbert group, Vaccine and Infectious Disease Division
Serotype is serious business for Dengue infection
From Gilbert Laboratory, Vaccine and Infectious Disease Division
5 questions on new dengue vaccine analysis
Asked to help re-examine clinical trial data, Fred Hutch biostatisticians foresee a new era of personalized vaccines
Fred Hutchinson Cancer Research Center designated MIDAS Center of Excellence
Designation puts Fred Hutch on cutting edge of U.S. analysis and response to infectious disease outbreaks around the globe - Center includes researchers from seven other academic sites across the country